Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

956 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.
Tsujino T, Komura K, Ichihashi A, Tsutsumi T, Matsunaga T, Yoshikawa Y, Maenosono R, Okita K, Takai T, Oide R, Minami K, Uehara H, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H. Tsujino T, et al. Among authors: okita k. Oncotarget. 2017 Nov 25;8(66):110311-110325. doi: 10.18632/oncotarget.22688. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299149 Free PMC article.
Long tube for obstructing left-sided colon cancer.
Adachi Y, Okita K, Nozoe T, Iso Y, Yoh R, Matsumata T. Adachi Y, et al. Among authors: okita k. Dig Surg. 1999;16(3):178-9. doi: 10.1159/000018723. Dig Surg. 1999. PMID: 10436363
Carcinoid tumor of the ileum with intestinal obstruction.
Nozoe T, Kuriyama A, Kitamura M, Iso Y, Okita K, Matsumata T, Kasai T, Hashimoto H, Sugimachi K. Nozoe T, et al. Among authors: okita k. Hepatogastroenterology. 1999 Mar-Apr;46(26):1013-5. Hepatogastroenterology. 1999. PMID: 10370659
CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb.
Nakano T, Okita K, Okazaki S, Yoshimoto S, Masuko S, Yagi H, Kato K, Tomioka Y, Imai K, Hamada Y, Masuko K, Shimada-Takaura K, Nagai N, Saya H, Arai T, Ishiwata T, Masuko T. Nakano T, et al. Among authors: okita k. FEBS Open Bio. 2025 Jan 5. doi: 10.1002/2211-5463.13963. Online ahead of print. FEBS Open Bio. 2025. PMID: 39757718 Free article.
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Murakami M, Miyata Y, Nakashima K, Abe M, Nishimura J, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakamura N, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Nakajima TE. Murakami M, et al. Among authors: okita k. Int J Clin Oncol. 2025 Jan;30(1):27-39. doi: 10.1007/s10147-024-02663-4. Epub 2024 Nov 21. Int J Clin Oncol. 2025. PMID: 39570460
956 results